Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

39.59
Delayed Data
As of Mar 24
 +0.30 / +0.76%
Today’s Change
25.98
Today|||52-Week Range
41.65
-1.52%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Simon Christopher
President & Chief Executive Officer
Buy8/04/201660,000$35.00$2.1M+13.70%
Burke William P /haemonetics/
Chief Financial Officer & Executive Vice President
Gift10/25/201610,413$34.21$356.2K+17.41%
Gelbman Ronald G
Director
Sale7/29/201611,614$30.09$349.5K+30.57%
Gelbman Ronald G
Director
Buy7/29/201611,758$29.72$349.4K+30.57%
Foote Susan Bartlett
Director
Sale8/05/20168,280$35.35$292.7K+11.80%
Foote Susan Bartlett
Director
Buy8/05/20168,580$27.24$233.7K+11.80%
Gelbman Ronald G
Director
Sale12/12/20165,683$40.30$229.0K-1.93%
Foote Susan Bartlett
Director
Sale8/05/20165,305$35.35$187.5K+11.80%
Basil Michelle L
General Counsel & Executive Vice President
Gift3/06/20174,879$38.43$187.5K+3.10%
Burzik Catherine M
Director
Gift10/25/20164,969$34.21$170.0K+17.41%
Page of 4